{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:46:37Z","timestamp":1783529197337,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003261"],"award-info":[{"award-number":["82003261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300420060"],"award-info":[{"award-number":["232300420060"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421428"],"award-info":[{"award-number":["252300421428"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152495","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T20:50:09Z","timestamp":1755550209000},"page":"152495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A membrane-bound IL-2 promotes CAR-NK cell proliferation, anti-apoptosis and anti-tumor activity"],"prefix":"10.1016","volume":"781","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-5728","authenticated-orcid":false,"given":"Changjiang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhuang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-5324","authenticated-orcid":false,"given":"Zhiyuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152495_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molimm.2023.01.010","article-title":"Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells","volume":"155","author":"Guo","year":"2023","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2025.152495_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2020.04.016","article-title":"A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis","volume":"122","author":"Lu","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrc.2025.152495_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fimmu.2019.00661","article-title":"NKG2D\/NKG2-ligand pathway offers new opportunities in cancer treatment","volume":"10","author":"Frazao","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152495_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40425-019-0564-6","article-title":"A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia","volume":"7","author":"Nguyen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2025.152495_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/cells13050451","article-title":"Building a better defense: expanding and improving natural killer cells for adoptive cell therapy","volume":"13","author":"Maia","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.152495_bib6","first-page":"650","article-title":"The next generation of cellular immunotherapy: chimeric antigen receptor-natural killer cells, transplant","volume":"28","author":"Moscarelli","year":"2022","journal-title":"Cell. Ther."},{"key":"10.1016\/j.bbrc.2025.152495_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.21873\/anticanres.13085","article-title":"Culturing the human natural killer cell line NK-92 in interleukin-2 and interleukin-15 \u2013 implications for clinical trials","volume":"39","author":"T\u00f6rnroos","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2025.152495_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112156","article-title":"IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: from bench to bedside","volume":"133","author":"Vahidi","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2025.152495_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1141208","article-title":"The role of interleukin-15 in the development and treatment of hematological malignancies","volume":"14","author":"Sindaco","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152495_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","article-title":"De novo design of potent and selective mimics of IL-2 and IL-15","volume":"565","author":"Silva","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152495_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1226518","article-title":"19 cells with the IL-15\/IL-15R\u03b1 complex improved proliferation and anti-tumor effect in vivo","volume":"14","author":"Silvestre","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152495_bib12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.omtm.2021.10.014","article-title":"piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells","volume":"23","author":"Du","year":"2021","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.bbrc.2025.152495_bib13","doi-asserted-by":"crossref","first-page":"eadd6997","DOI":"10.1126\/sciadv.add6997","article-title":"Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2025.152495_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186890","article-title":"First-in-human trial of engineered NK cells in lung cancer refractory to immune checkpoint inhibitors","author":"Villalona-Calero","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2025.152495_bib15","doi-asserted-by":"crossref","first-page":"E7788","DOI":"10.1073\/pnas.1610544113","article-title":"Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells","volume":"113","author":"Hurton","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2025.152495_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood-2014-02-556837","article-title":"Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15","volume":"124","author":"Imamura","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2025.152495_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005582","article-title":"Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR tregs and confers resistance to calcineurin inhibitors","volume":"13","author":"Kremer","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152495_bib18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.7150\/thno.79942","article-title":"Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity","volume":"13","author":"Shin","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2025.152495_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2127282","article-title":"A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity","volume":"11","author":"Xiong","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.bbrc.2025.152495_bib20","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.4110\/in.2025.25.e17","article-title":"Cytokines in focus: IL-2 and IL-15 in NK adoptive cell cancer immunotherapy","volume":"25","author":"Marr","year":"2025","journal-title":"Immun. Netw."},{"key":"10.1016\/j.bbrc.2025.152495_bib21","article-title":"Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK\/T cell lymphoma","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2025.152495_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2020.00167","article-title":"NK cell-based immune checkpoint inhibition","volume":"11","author":"Khan","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25012100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25012100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:26:05Z","timestamp":1775834765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25012100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"alternative-id":["S0006291X25012100"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152495","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A membrane-bound IL-2 promotes CAR-NK cell proliferation, anti-apoptosis and anti-tumor activity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152495"}}